Trinity Capital Inc. Funds a Record $1.2 Billion of Investments in 2024
Company originates $1.6 billion of new commitments in 2024 PHOENIX, Jan. 13, 2025 /PRNewswire/ -- Trinity Capital Inc. (Nasdaq: TRIN) ("Trinity" or the...
Month: January 2025
Neuronetics Provides Business Update and Issues 2025 Guidance
Preliminary unaudited fourth quarter and full year revenue 2024 was $22.1 and $74.5, respectivelyClosed acquisition of Greenbrook TMS effective as...
SuperCom Secures First Agency Contract in Ohio, Rapid U.S Expansion Continues
This Marks 20th New Contract and Sixth New State Entry in the U.S. Since Summer of 2024 TEL AVIV, Israel,...
Salarius Pharmaceuticals and Decoy Therapeutics Announce Definitive Merger Agreement
Decoy’s proprietary IMP3ACT™ peptide conjugate drug design and manufacturing platform leverages machine learning (ML) and artificial intelligence (AI) tools Decoy...
Shake Shack Provides Fourth Quarter 2024 Business Update and Long-Term Targets
NEW YORK--(BUSINESS WIRE)--Shake Shack Inc. (“Shake Shack” or the “Company”) (NYSE: SHAK) announced preliminary unaudited results for the fiscal fourth...
Rezolve Ai Poised for Global Growth as it enters 2025 with Strong Customer Acquisitions, Strategic Partnerships, and Groundbreaking Innovations
NEW YORK, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV) is entering 2025 with momentum, announcing customer acquisitions...
Quantum-Si Launches Platinum® Pro: The End-to-End Solution for Deeper Insights in Proteomics
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, announces the launch of Platinum®...
Postal Realty Trust, Inc. Provides Fourth Quarter and Full Year 2024 Update
- Executed New Leases with 3% Annual Rent Escalations & Ten-Year Term -- Acquired 197 Properties for $91 Million in...
Update: Profound Medical’s Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th
TORONTO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device...
Phio Pharmaceuticals Announces Promising Results of Second Cohort from Its Ongoing Clinical Study of PH-762
Marlborough, Massachusetts--(Newsfile Corp. - January 13, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics...
Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference
NEW YORK, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a transformative fertility, family...
Potbelly Corporation Reports Preliminary Results for Fourth Fiscal Quarter of 2024
Company to host a fireside chat and investor meetings at the 27th Annual ICR Conference Company expects to deliver positive...
24/7 Market News Snapshot 13 January, 2025 – Salarius Pharmaceuticals, Inc. Common Stock (NASDAQ:SLRX)
DENVER, Colo., 13 January, 2025 (247marketnews.com) – (NASDAQ:SLRX) are discussed in this article. Salarius Pharmaceuticals, Inc. (SLRX) has recently announced...
RUA GOLD Utilizes VRIFY AI to Prioritize Cumberland, Following up on Exceptional Historic Drill Intercept
Vancouver, British Columbia--(Newsfile Corp. - January 13, 2025) - Rua Gold Inc. (TSXV: RUA) (OTCQB: NZAUF) (WKN: A40QYC) ("RUA GOLD"...
Nurix Therapeutics Outlines 2025 Goals and Objectives for Advancement of Its Robust Pipeline in Cancer and Autoimmune Diseases
Initiate a suite of clinical trials in 2025 intended to support global registration of NX-5948 for the treatment of chronic...
Mega Matrix Inc. Announced that Romantic Drama Micro-drama “Runaway Billionaire Becomes My Groom” Now Streaming on FlexTV
SINGAPORE, Jan. 13, 2025 /PRNewswire/ -- Mega Matrix Inc. (NYSE American: MPU) announced that the romantic drama short drama Runaway...
Kyverna Therapeutics to Highlight Near-Term Strategic Priorities and Key Milestones at the 43rd Annual J.P. Morgan Healthcare Conference
Extending Company's leadership position in autoimmune CAR T with prioritized indication strategy; pivoting to late-stage development and commercialization First-to-market opportunity...
KBR Awarded Global Agreement by BP for Engineering, Procurement and Construction Management Services
HOUSTON, Jan. 13, 2025 /PRNewswire/ -- KBR (NYSE: KBR) announced today it has been awarded a global agreement by BP...
Southern California Wildfires Highlight need for Improved Building Technologies
DENVER, Colo., Jan 13, 2025 (247marketnews.com)- The global insurance industry is reaching a breaking point, with relentless wildfires making regions,...
Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.
Acquisition includes CAPLYTA® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and...
IceCure Medical CEO Issues Letter to Shareholders & Reports Increase of 42% in ProSense® Sales for 2024 in North America
Increase in sales of ProSense®, based on preliminary unaudited results, demonstrate growing adoption of ProSense® cryoablation for breast tumors. FDA decision...
iBio Announces New Investments from Board Members and Officers
SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA: IBIO), an AI-driven innovator of precision antibody immunotherapies, announced...
Glow Lifetech Announces Expansion into New Brunswick Market with MOD(TM) Drops, Marking Atlantic Canada Debut
Toronto, Ontario--(Newsfile Corp. - January 13, 2025) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the...
Five Below, Inc. Announces Holiday Sales Results for Quarter-To-Date Through January 4, 2025
PHILADELPHIA, PA, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ: FIVE) ("Five Below" or the "Company") today announced...
EnviroGold Global Closes Upsized Strategic Unit Offering to Raise $4.1 Million and Announces Appointment of New Director
TORONTO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) (“EnviroGold” or...
Enerflex Ltd. Provides Preliminary Outlook for 2025 and Confirms Timing of Fourth Quarter Release
CALGARY, Alberta, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) (“Enerflex” or the “Company”) is pleased...
Destination XL Group, Inc. Reports Holiday Sales Results
CANTON, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. (NASDAQ: DXLG), the leading integrated-commerce specialty retailer of...
24/7 Market News Snapshot 13 January, 2025 – bioAffinity Technologies, Inc. Common Stock (NASDAQ:BIAF)
DENVER, Colo., 13 January, 2025 (247marketnews.com) – (NASDAQ:BIAF) are discussed in this article. bioAffinity Technologies, Inc. (BIAF) is currently experiencing...
Defense Metals Announces Share-Based Interest Payment
VANCOUVER, BC, Jan. 13, 2025 /PRNewswire/ - Defense Metals Corp. ("Defense Metals" or the "Company"; (TSXV: DEFN) (OTCQB: DFMTF) (FSE: 35D)...
24/7 Market News Snapshot 13 January, 2025 – X4 Pharmaceuticals, Inc. Common Stock (NASDAQ:XFOR)
DENVER, Colo., 13 January, 2025 (247marketnews.com) – (NASDAQ:XFOR) are discussed in this article. X4 Pharmaceuticals, Inc. has demonstrated a significant...
Beam Therapeutics Announces Progress in Hematology and Genetic Disease Franchises and Outlines Key 2025 Anticipated Catalysts
More Than 40 Adult Sickle Cell Disease Patients Now Enrolled in BEACON Trial of BEAM-101; Beam Expects to Dose 30...
Atea Pharmaceuticals to Highlight 2025 Strategic Priorities at the 43rd Annual J.P. Morgan Healthcare Conference
Global Phase 3 HCV Program Expected to Initiate in 1Q 2025 Potential Best-in-Class Profile of Bemnifosbuvir + Ruzasvir Regimen Supports...
Aquestive Therapeutics Provides Business Update and Outlines Key 2025 Objectives
On track to submit Anaphylm™ (epinephrine) Sublingual Film NDA in Q1 2025Actively recruiting subjects in the Anaphylm pediatric clinical trialSuccessfully...
ANI Pharmaceuticals Provides Preliminary Fourth Quarter and 2024 Financial Results and Preliminary 2025 Outlook
For full year 2024, the Company expects total net revenues, adjusted non-GAAP EBITDA, and adjusted non-GAAP diluted EPS to be...
Abercrombie & Fitch Co. Increases Fourth Quarter and Full Year Net Sales Outlook on Better-Than-Expected Holiday Sales
Company increases fourth quarter net sales growth outlook to a range of 7-8% from prior range of 5-7%Increases full year...
a.k.a. Brands Holding Corp. Announces Preliminary Fourth Quarter and Fiscal 2024 Results
SAN FRANCISCO--(BUSINESS WIRE)--a.k.a. Brands Holding Corp. (NYSE: AKA), a portfolio of next generation fashion brands, today announced preliminary financial results...
AirSculpt Technologies Updates Fiscal Year 2024 Guidance in Advance of its Participation in the ICR Conference 2025
MIAMI BEACH, Fla., Jan. 13, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ: AIRS) (“AirSculpt” or the “Company”), an industry...
Alamos Gold Continues to Define High-Grade Mineralization Across the Island Gold Deposit; Ongoing Success Expected to Drive Additional Growth in Mineral Reserves and Resources
All amounts are in United States dollars, unless otherwise stated. TORONTO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Alamos Gold Inc....
ADMA Biologics Announces Preliminary Full Year 2024 Revenue and Provides Business Update
FY 2024 Preliminary Unaudited Total Revenue of Approximately $417-425 Million, Exceeding Previous Guidance of $415 Million YE 2024 Total Cash...
24/7 Market News Snapshot 13 January, 2025 – Phio Pharmaceuticals Corp. Common Stock (NASDAQ:PHIO)
DENVER, Colo., 13 January, 2025 (247marketnews.com) – (NASDAQ:PHIO) are discussed in this article. Phio Pharmaceuticals Corp. has recently experienced a...